Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Neoadjuvant Study"'
Autor:
Sungchan Gwark, Woo Chul Noh, Sei Hyun Ahn, Eun Sook Lee, Yongsik Jung, Lee Su Kim, Wonshik Han, Seok Jin Nam, Gyungyub Gong, Seon-Ok Kim, Hee Jeong Kim
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
In this study, we aimed to evaluate axillary lymph node dissection (ALND) rates and prognosis in neoadjuvant chemotherapy (NCT) compare with neoadjuvant endocrine therapy (NET) in estrogen receptor-positive (ER+)/human epidermal growth factor recepto
Externí odkaz:
https://doaj.org/article/ac09cd0da95748909c0484197389a9db
Autor:
Gyungyub Gong, Woo Chul Noh, Seok Jin Nam, Hee Jeong Kim, Sei Hyun Ahn, Sungchan Gwark, Eun Sook Lee, Wonshik Han, Seon-Ok Kim, Lee Su Kim, Yong Sik Jung
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
In this study, we aimed to evaluate axillary lymph node dissection (ALND) rates and prognosis in neoadjuvant chemotherapy (NCT) compare with neoadjuvant endocrine therapy (NET) in estrogen receptor-positive (ER+)/human epidermal growth factor recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb999f7bdde3d8ed8bea508aa7ebcec
Autor:
James O. Jones, Sarah J. Welsh, Stephan Ursprung, Ferdia A. Gallagher, Christopher Irwin Smith, Grant D. Stewart
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Venous tumor thrombus (VTT) extension occurs in 4-15% cases of renal cell cancer (RCC). Although surgery is performed with curative intent, mortality is high (5-15%). The...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c07d3fd51e3e4f8cda3f64f5518a98d0
https://doi.org/10.1097/ju.0000000000002149.05
https://doi.org/10.1097/ju.0000000000002149.05
Autor:
Hanna Y. Irie, Erika Hamilton, Yongqiang Tang, Leif W. Ellisen, Sebastien Hazard, James Reeves, Ming Shan, Minetta C. Liu, Peng Pan, Steven J. Isakoff, Laura Spring, Cesar A. Santa-Maria, Hyo S. Han, J.R. Graham
Publikováno v:
Breast, Vol 56, Iss, Pp S55-S56 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24df1ca9ae9217dad7f82f9d203c7a96
http://www.sciencedirect.com/science/article/pii/S0960977621001831
http://www.sciencedirect.com/science/article/pii/S0960977621001831
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P.G. Aftimos, Christel Fontaine, Barbara Pistilli, D. Taylor, J-L Canon, M.J. Piccart, Hannelore Denys, Elisa Agostinetto, P. Neven, M Ignatiadis, Isabelle Veys, François Duhoux, Laurence Buisseret, Florence Coussy, C. Chakiba, Marianne Paesmans, L. Ameye
Publikováno v:
Annals of Oncology. 32:S52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4d0e8d68d6d870b40d6c9d23904537c
https://doi.org/10.1016/j.annonc.2021.03.086
https://doi.org/10.1016/j.annonc.2021.03.086
Autor:
Steve Leung, Abdel Hamid, Alexander Laird, Lisa Hopcroft, Stephan Ursprung, Michelle Welsh, Balaji Venugopal, Robert Jones, Tim Eisen, Iosif Mendichovszky, Axel Bex, Sarah J. Welsh, Ferdia A. Gallagher, Jahangeer Malik, Kathleen Riddle, Grenville Oades, Ekaterini Boleti, Faiz Mumtaz, Antony C. P. Riddick, Grant D. Stewart
Publikováno v:
Journal of Clinical Oncology. 39:275-275
275 Background: Venous tumor thrombus (VTT) extension occurs in 4-15% cases of renal cell cancer (RCC). The Mayo classification distinguishes 4 levels of VTT extension between the renal vein and supradiaphragmatic inferior vena cava (IVC). Although s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ac55a437a3f8c6c1848c2a0f7498d0e
https://doi.org/10.1200/jco.2021.39.6_suppl.275
https://doi.org/10.1200/jco.2021.39.6_suppl.275
Autor:
Stephanie Akbari, James Pellicane, Paul Richards, Lisette Stork-Sloots, Mark A. Gittleman, LL Lee, Jennifer Beatty, F de Snoo, P Whitworth, Michael Rotkis, Angela Mislowsky, Charles Nash, P Baron, Mary Murray, Peter D. Beitsch, Sarah Untch, Carrie L. Dul
Publikováno v:
Cancer Research. 76:P4-14
Background The phase 4 Neo-adjuvant Breast Registry Symphony Trial (NBRST) enrolled over 1,000 US patients between June 2011 and December 2014. The aim of NBRST study is to compare chemo-sensitivity as defined by pathological Complete Response (pCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::864e3a57adf41c9ee014358adcf8a200
https://doi.org/10.1158/1538-7445.sabcs15-p4-14-29
https://doi.org/10.1158/1538-7445.sabcs15-p4-14-29
Autor:
C. Balana, Sonia Del Barco, Juan Sepulveda, Eugenia Verger, Jose Maria Velarde, Juan José García Mosquera, Anna Estival, Ana Herrero, Maria Martinez Garcia, M. Gil, Raquel Luque, Carlos Mesia, Iris Teruel, Salvador Villà, Ramon De Las Penas, Oscar Gallego, Estela Pineda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754077f49640642ac373c1ca377d8bc1
https://europepmc.org/articles/PMC5692347/
https://europepmc.org/articles/PMC5692347/
Autor:
Huihui Ye, Mary-Ellen Taplin, Zhenyang Jiang, Alvin M. Matsumoto, Glenn J. Bubley, Arturo Molina, Wanling Xie, John W. Davis, Trevor M. Penning, Elahe A. Mostaghel, Massimo Loda, Philip W. Kantoff, Brett T. Marck, Martin G. Sanda, Christopher J. Logothetis, Bruce Montgomery, Rosina T. Lis, Nam Phuong Tran, Lawrence D. True, Daniel Tamae, Weimin Peng, Peter S. Nelson, Patricia Troncoso, C. M. Haqq, Bruce L. Dalkin, Jerome P. Richie, Steven P. Balk, Thian Kheoh
Publikováno v:
Journal of Clinical Oncology. 32:3705-3715
Purpose Cure rates for localized high-risk prostate cancers (PCa) and some intermediate-risk PCa are frequently suboptimal with local therapy. Outcomes are improved by concomitant androgen-deprivation therapy (ADT) with radiation therapy, but not by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e012d509fe2d629acef0336837bc82
https://doi.org/10.1200/jco.2013.53.4578
https://doi.org/10.1200/jco.2013.53.4578